Greenleaf Peter Insider Trades & Stock Holdings
Greenleaf Peter, Director at Pelthos Therapeutics Inc. has 1 Form 4 trade on file since Oct 2, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($16.87K), net -$16.87K. Latest filing: disposed of 797 shares of $PTHS on Oct 2, 2026 at $21.17.
- Trades on file
- 1
- Open-market bought
- $0
- Open-market sold
- $16.87K
- Net open-market
- -$16.87K
- Latest filing
- Oct 2, 2026
All insider trades by Greenleaf Peter
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $PTHS | Sell (Open-market sale) 10b5-1 | 797 | $21.17 | $16.87K | Director | — |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Greenleaf Peter traded
Frequently asked questions
Has Greenleaf Peter been buying or selling stock?
Greenleaf Peter has 0 open-market purchases and 1 open-market sale on file, net -$16.87K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Greenleaf Peter's latest insider trade?
disposed of 797 shares of $PTHS on Oct 2, 2026 at $21.17.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.